Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 1
2001 1
2004 1
2005 1
2007 2
2008 3
2009 1
2010 2
2011 2
2012 2
2013 2
2014 2
2015 2
2018 3
2019 3
2020 3
2021 4
2022 9
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma.
Okada T, Fushimi C, Matsuki T, Okamoto I, Sato H, Kondo T, Tokashiki K, Kishida T, Ito T, Yamashita G, Aihara Y, Hanyu K, Kushihashi Y, Masubuchi T, Tada Y, Miura K, Harada Y, Momiyama K, Yamashita T, Omura GO, Takahashi H, Oridate N, Tsukahara K. Okada T, et al. Among authors: momiyama k. Anticancer Res. 2022 Mar;42(3):1607-1613. doi: 10.21873/anticanres.15635. Anticancer Res. 2022. PMID: 35220258
Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma.
Nagai H, Mukozu T, Kobayashi K, Nogami A, Nagumo H, Mohri K, Watanabe G, Amanuma M, Yoshimine N, Ogino Y, Matsui D, Daido Y, Matsukiyo Y, Matsui T, Wakui N, Momiyama K, Higai K, Matsuda T. Nagai H, et al. Among authors: momiyama k. Oncology. 2023;101(1):32-40. doi: 10.1159/000527306. Epub 2022 Oct 3. Oncology. 2023. PMID: 36191570 Free PMC article.
Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.
Mukozu T, Nagai H, Matsui D, Mohri K, Watanabe G, Yoshimine N, Amanuma M, Kobayashi K, Ogino Y, Matsukiyo Y, Matsui T, Daido Y, Wakui N, Shinohara M, Momiyama K, Higai K, Igarashi Y. Mukozu T, et al. Among authors: momiyama k. Cancer Chemother Pharmacol. 2022 Jan;89(1):11-20. doi: 10.1007/s00280-021-04359-2. Epub 2021 Oct 10. Cancer Chemother Pharmacol. 2022. PMID: 34628536
40 results